Last reviewed · How we verify
Vehicle of ADX-102 Ophthalmic Drops — Competitive Intelligence Brief
phase 3
ROS scavenger / Antioxidant
Reactive oxygen species (ROS)
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vehicle of ADX-102 Ophthalmic Drops (Vehicle of ADX-102 Ophthalmic Drops) — Aldeyra Therapeutics, Inc.. This is a vehicle formulation (inactive carrier system) for ADX-102, designed to deliver the active pharmaceutical ingredient to the ocular surface.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vehicle of ADX-102 Ophthalmic Drops TARGET | Vehicle of ADX-102 Ophthalmic Drops | Aldeyra Therapeutics, Inc. | phase 3 | ROS scavenger / Antioxidant | Reactive oxygen species (ROS) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (ROS scavenger / Antioxidant class)
- Aldeyra Therapeutics, Inc. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vehicle of ADX-102 Ophthalmic Drops CI watch — RSS
- Vehicle of ADX-102 Ophthalmic Drops CI watch — Atom
- Vehicle of ADX-102 Ophthalmic Drops CI watch — JSON
- Vehicle of ADX-102 Ophthalmic Drops alone — RSS
- Whole ROS scavenger / Antioxidant class — RSS
Cite this brief
Drug Landscape (2026). Vehicle of ADX-102 Ophthalmic Drops — Competitive Intelligence Brief. https://druglandscape.com/ci/vehicle-of-adx-102-ophthalmic-drops. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab